×

WHO says antimicrobial resistance efforts improve globally but remain off track for 2030 goals

By Thomson Reuters Nov 16, 2026 | 2:02 AM

By Mariam Sunny

Nov 16 (Reuters) – More countries have adopted plans to combat antimicrobial resistance (AMR) this year, but most are failing to translate commitments into funded programs, leaving the world off pace to meet key 2030 targets, the World ​Health Organization said.

Of 183 countries surveyed, 173 reported having a national action ‌plan to tackle AMR, up from 79 in 2017. Only 42, however, said their plans were financed and implemented.

The annual survey is conducted by the WHO, the United Nations Environment Programme, the World Organization for Animal Health and the Food and Agriculture Organization.

Antibiotic resistance occurs when germs evolve and no longer ‌respond to ​drugs, often following misuse and overuse of the medicines, ⁠according to the WHO.

At the ⁠UN General Assembly in 2024, countries agreed to a series of targets for 2030 aimed at tackling the problem, which experts warn could undermine decades of medical advances.

“Procedures we now take for granted become far riskier when antibiotics and antimicrobials no longer ​work,” Jean Pierre Nyemazi, acting director of the WHO’s AMR department, said. The development of new antibiotics is not keeping pace with the spread of resistance, Nyemazi said.

One ⁠in six laboratory-confirmed bacterial infections is resistant to ⁠antibiotics, and drug-resistant infections could contribute to more than 39 million ​deaths worldwide over the next 25 years, if current trends persist, according to the WHO.

PREVENTION FALLS ​SHORT

The 2026 survey flagged a critical gap in infection prevention, one of ‌the most effective ways to reduce the need for antibiotics.

The WHO said 128 countries now have national infection prevention and control programs and guidelines, up from 90 countries in 2018. Yet only 69 countries, or 38%, have implemented these programs nationwide — far short of ⁠the target of 90% by 2030.

While 131 countries reported having a national reference laboratory capable of testing antibiotic resistance in common bacteria, only 66 countries can test for both bacterial and ⁠fungal resistance.

Countries agreed in 2024 ‌to work toward ensuring that 80% have such capabilities by ⁠2030.

The WHO also released two toolkits to help countries strengthen diagnostic ​capacity, ‌one outlining essential tests and another detailing laboratory procedures.

Surveillance systems have ​expanded significantly, ⁠the report said, with 113 countries now monitoring antibiotic use and 109 tracking resistance, compared with 65 and 39 countries, respectively, in 2017.

But only 21 countries reported integrating both datasets, a step the WHO says is critical to understand how antibiotic use is driving resistance and help guide national strategies to contain it.

(Reporting by Mariam Sunny in Bengaluru; editing by Nancy ​Lapid and Joyjeet Das)